Skip to the content
  • Our Company
    • Leadership
    • Board of Directors
  • Science & Innovation
    • Our Approach
    • Our Pipeline
  • Culture
  • Media
    • Resources
    • News
  • News
  • Contact
Menu
  • Our Company
    • Leadership
    • Board of Directors
  • Science & Innovation
    • Our Approach
    • Our Pipeline
  • Culture
  • Media
    • Resources
    • News
  • News
  • Contact

Press Releases

The landscape of antibody binding in SARS-CoV-2 infection

June 18, 2021
READ MORE

Immunoreactive peptide maps of SARS-CoV-2

February 12, 2021
READ MORE

Engineering Selective Stability for Activated-Tumor Specific TCBs

February 1, 2021
READ MORE

Assaying for Stability of Peptides in Serum

February 1, 2021
READ MORE

Affinity Optimization of a Cyclic Peptide

February 1, 2021
READ MORE

Discovery Workflow

February 1, 2021
READ MORE
   PAGE Page1 Page2 Page3 Page4 Page5 … Page10
  • Our Team
  • Our Pipeline
  • Partner
  • Resources
  • News
  • Careers
  • Contact
  • Our Team
  • Our Pipeline
  • Partner
  • Resources
  • News
  • Careers
  • Contact
  • CONNECT ON LINKEDIN

Copyright © 2024 Nimble Therapeutics, Inc